Skip to article
Astra

Critical Care

Distributive Shock

Distributive shock is acute circulatory failure from pathologic vasodilation and maldistributed flow. Rapidly identify the precipitant, assess for concurrent hypovolemic, cardiogenic, or obstructive physiology, treat the cause, restore perfusion with individualized fluid resuscitation, and initiate vasopressors without delaying definitive therapy.ScienceDirectShock (Circulatory) - an overviewScienceDirectShock: causes, initial assessment and investigations

Clinical question: How should clinicians identify, differentiate, and manage distributive shock while avoiding delayed treatment of its cause or fluid overload?

Recognition

Recognize distributive physiology and exclude mixed shock

Hypotension alone is insufficient; identify tissue hypoperfusion and the mechanism of circulatory failure.

Distributive shock reflects pathologic vasodilation and impaired vascular responsiveness, producing inadequate effective arterial filling and tissue oxygen utilization. Common causes are sepsis, anaphylaxis, neurogenic shock, pancreatitis, and post-cardiotomy vasoplegia. Septic shock accounts for most distributive shock and may initially be hyperdynamic, but sepsis-associated myocardial dysfunction can convert the phenotype to mixed distributive-cardiogenic shock.ScienceDirectShock (Circulatory) - an overviewPubMedShock - StatPearls - NCBI Bookshelf - NIH

Treat shock as a physiologic syndrome rather than a single diagnosis. Hypotension, elevated lactate, oliguria, altered mentation, delayed capillary refill, mottling, and cool extremities indicate hypoperfusion, although early septic shock can present with warm, flushed skin and preserved or high cardiac output.ScienceDirectShock (Circulatory) - an overviewScienceDirectShock: causes, initial assessment and investigationsPubMedShock - StatPearls - NCBI Bookshelf - NIH

A presumed distributive cause does not exclude hemorrhage, acute coronary syndrome, pulmonary embolism, tamponade, tension pneumothorax, or medication-associated vasodilation. Reassess whenever vasopressor requirements escalate, lactate fails to improve, pulmonary edema develops, or bedside findings are discordant with the presumed phenotype.ScienceDirectShock (Circulatory) - an overviewScienceDirectShock: causes, initial assessment and investigations

Clinical features that help distinguish major shock phenotypes; overlap is frequent and mixed shock requires repeated reassessment.ScienceDirectShock (Circulatory) - an overviewScienceDirectShock: causes, initial assessment and investigationsPubMedShock - StatPearls - NCBI Bookshelf - NIH
PhenotypeTypical hemodynamicsHigh-yield cluesImmediate priority
DistributiveLow SVR; cardiac output often high early but variable later.ScienceDirectShock (Circulatory) - an overviewSepsis: suspected infection, vasoplegia, possible warm skin early; anaphylaxis: rapid allergic exposure with airway, breathing, or circulatory compromise; neurogenic shock may include bradycardia after spinal injury.ScienceDirectShock (Circulatory) - an overviewPubMedShock - StatPearls - NCBI Bookshelf - NIHPubMedEmergency treatment of anaphylaxis: concise clinical guidanceTreat cause, give carefully reassessed fluids, and support MAP with vasopressors.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedShock - StatPearls - NCBI Bookshelf - NIHPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Hypovolemic/hemorrhagicLow preload and cardiac output with compensatory vasoconstriction.ScienceDirectShock (Circulatory) - an overviewBleeding, gastrointestinal or renal losses, dry mucosa, low JVP, falling hemoglobin when not hemoconcentrated.ScienceDirectShock (Circulatory) - an overviewPubMedShock - StatPearls - NCBI Bookshelf - NIHControl loss and restore intravascular volume; use blood-product resuscitation when hemorrhage is present.ScienceDirectShock (Circulatory) - an overview
CardiogenicLow cardiac output with elevated filling pressures in typical congestive phenotypes.ScienceDirectShock (Circulatory) - an overviewPulmonary congestion, elevated JVP, cool extremities, ECG changes, arrhythmia, or new ventricular dysfunction.ScienceDirectShock (Circulatory) - an overviewPubMedShock - StatPearls - NCBI Bookshelf - NIHIdentify ischemic, arrhythmic, mechanical, or pump-failure cause; avoid indiscriminate fluid loading.ScienceDirectShock (Circulatory) - an overviewScienceDirectProtocolised Management of Cardiogenic Shock and Shock Teams: A Narrative Review
ObstructiveReduced cardiac output despite generally preserved contractility; CVP is often increased.ScienceDirectShock (Circulatory) - an overviewTamponade, tension pneumothorax, massive pulmonary embolism, or excessive intrathoracic pressure.ScienceDirectShock (Circulatory) - an overviewPubMedShock - StatPearls - NCBI Bookshelf - NIHRelieve obstruction immediately; do not delay definitive treatment for confirmatory testing in extremis.ScienceDirectShock (Circulatory) - an overview

Most Common Cause

Manage septic vasodilatory shock

Source control, effective antimicrobials, individualized resuscitation, and vasopressor support should proceed in parallel.

Septic shock is sepsis with vasopressor requirement to maintain MAP at least 65 mmHg and lactate above 2 mmol/L despite adequate fluid resuscitation.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024 Antimicrobial therapy and source control are the time-critical disease-modifying interventions. Obtain blood cultures and source-directed specimens before antimicrobials when feasible, but do not permit testing to delay treatment in a patient with shock.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

Initial fluid therapy should address suspected reduced intravascular volume while avoiding fluid accumulation. Balanced crystalloids are preferred over normal saline in the cited sepsis guidance. Some patients require at least 30 mL/kg within 3 hours, but subsequent fluids should be individualized using response to a small bolus, dynamic measures of fluid responsiveness, bedside echocardiography, and evidence of fluid intolerance or congestion.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

Norepinephrine is first-line for septic shock and should be started early when hypotension persists during resuscitation; the cited review describes 0.1 to 1.2 micrograms/kg/min. A MAP target of 65 mmHg is appropriate initially for most patients. Vasopressin is an adjunct when norepinephrine alone does not achieve the target; epinephrine is generally reserved for inadequate pressure control despite norepinephrine and vasopressin or when inotropic effects are needed.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

Septic vasodilatory shock decisions supported by cited sepsis reviews and guidelines.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
DecisionActionMonitoring or trigger for escalation
Initial resuscitationUse balanced crystalloids; assess volume status, fluid responsiveness, and fluid tolerance repeatedly rather than administering an unbounded fixed volume.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024Monitor MAP, lactate, capillary refill, urine output, pulmonary congestion, and echocardiographic findings.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
First vasopressorStart norepinephrine for persistent hypotension during resuscitation; target MAP 65 mmHg initially.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024Escalate if MAP remains below target or tissue hypoperfusion persists despite appropriate resuscitation.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Second vasopressorAdd vasopressin when norepinephrine alone does not provide adequate pressure support.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024Monitor for ischemic complications and reassess for occult hypovolemia, cardiogenic dysfunction, or unresolved source.ScienceDirectShock (Circulatory) - an overviewPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Refractory shockConsider hydrocortisone 200 mg/day when shock remains vasopressor dependent despite fluids and vasopressors.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsAssess glucose, infection complications, gastrointestinal bleeding risk, and vasopressor duration.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Cardiac dysfunctionUse echocardiography to identify sepsis-associated myocardial dysfunction; evidence is insufficient to establish one optimal inotrope or mechanical-support strategy in this setting.PubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024If persistent hypoperfusion accompanies reduced cardiac function despite adequate MAP and resuscitation, pursue expert hemodynamic evaluation.PubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

Source control and antimicrobials

Abdominal, urinary obstructive, pleural, necrotizing soft-tissue, and catheter-related sources often require procedural rather than pharmacologic control. Source control should occur as soon as possible after sepsis recognition when the source is amenable to drainage, debridement, removal, decompression, or surgery.PubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

Cause-Specific Emergency

Treat anaphylactic shock with epinephrine first

Do not substitute adjunctive therapies for epinephrine in anaphylaxis with airway, breathing, or circulatory compromise.

Anaphylaxis is a rapid systemic hypersensitivity reaction characterized by airway, breathing, and/or circulatory compromise; cutaneous findings may be absent. The immediate first-line treatment is intramuscular epinephrine. Prompt administration is associated with better outcomes, and a second intramuscular dose should be administered after 5 minutes if ABC compromise persists.PubMedEmergency treatment of anaphylaxis: concise clinical guidance

Place the patient supine with legs elevated when feasible to maximize venous return. Give oxygen, establish IV or intraosseous access, and provide IV fluid resuscitation for shock or poor response to epinephrine. Refractory anaphylaxis is persistent ABC compromise after two appropriate intramuscular doses and warrants urgent critical care support and a titrated low-dose IV epinephrine infusion by clinicians experienced with vasopressors and continuous monitoring.PubMedEmergency treatment of anaphylaxis: concise clinical guidance

Anaphylactic shock actions from the cited emergency anaphylaxis guidance.PubMedEmergency treatment of anaphylaxis: concise clinical guidance
Clinical situationAction
Suspected anaphylaxis with ABC compromiseGive IM epinephrine immediately; do not wait for rash, tryptase, or IV access.PubMedEmergency treatment of anaphylaxis: concise clinical guidance
Persistent ABC compromise after 5 minutesRepeat IM epinephrine and continue supportive care.PubMedEmergency treatment of anaphylaxis: concise clinical guidance
Shock or poor responseAdminister IV fluids and optimize positioning to support venous return.PubMedEmergency treatment of anaphylaxis: concise clinical guidance
Persistent compromise after two IM dosesTreat as refractory anaphylaxis; obtain expert support for monitored low-dose IV epinephrine infusion.PubMedEmergency treatment of anaphylaxis: concise clinical guidance
After stabilizationObserve in a setting capable of treating recurrent ABC compromise; observation duration should be risk-stratified by severity and epinephrine requirement.PubMedEmergency treatment of anaphylaxis: concise clinical guidance

Other Etiologies

Address neurogenic and nonseptic vasodilatory causes directly

Vasopressor selection and fluid strategy must match the mechanism, not merely the blood pressure.

Neurogenic shock follows disruption of sympathetic pathways, most often after traumatic spinal cord injury, producing low vascular resistance, reduced venous return, and often bradycardia. Supportive care includes continuous hemodynamic and respiratory monitoring, treatment of the spinal injury, and vasoconstrictor support; norepinephrine may be useful when both vasoconstriction and inotropy are needed, whereas phenylephrine may be appropriate in selected circumstances.ScienceDirectShock (Circulatory) - an overview

Other nonseptic vasodilatory states include post-cardiopulmonary-bypass vasoplegia, pancreatitis, medication-associated vasodilation, adrenal crisis, and severe inflammatory states. These presentations require active evaluation for mixed shock and targeted treatment of the precipitant; generalized vasopressor escalation without diagnostic reassessment can miss pump failure, hemorrhage, or obstruction.ScienceDirectShock (Circulatory) - an overviewScienceDirectShock: causes, initial assessment and investigationsPubMedShock - StatPearls - NCBI Bookshelf - NIH

Selected nonseptic distributive-shock mechanisms and immediate priorities.ScienceDirectShock (Circulatory) - an overviewPubMedShock - StatPearls - NCBI Bookshelf - NIHPubMedEmergency treatment of anaphylaxis: concise clinical guidance
CauseMechanistic clueImmediate priority
AnaphylaxisMast-cell mediator release causes vasodilation, vascular leak, bronchospasm, and possible myocardial dysfunction.ScienceDirectShock (Circulatory) - an overviewPubMedEmergency treatment of anaphylaxis: concise clinical guidanceIM epinephrine, positioning, oxygen, IV fluids for shock, and escalation to monitored IV epinephrine infusion if refractory.PubMedEmergency treatment of anaphylaxis: concise clinical guidance
Neurogenic shockLoss of sympathetic tone after spinal cord injury causes vasodilation, reduced venous return, and possible bradycardia.ScienceDirectShock (Circulatory) - an overviewSupport perfusion with vasoconstrictors while evaluating for concurrent hemorrhage and treating the spinal injury.ScienceDirectShock (Circulatory) - an overview
Post-cardiotomy vasoplegiaProfound vasodilation after cardiopulmonary bypass can resemble septic vasodilatory shock.ScienceDirectShock (Circulatory) - an overviewAssess cardiac output and filling; use vasopressor support while addressing postoperative contributors.ScienceDirectShock (Circulatory) - an overview
Medication-associated vasodilationSedatives, opioids, vasodilators, and other drugs can contribute to pharmacologic shock.PubMedShock - StatPearls - NCBI Bookshelf - NIHStop or reverse the precipitant when possible and support circulation while excluding alternative causes.PubMedShock - StatPearls - NCBI Bookshelf - NIH

Monitoring

Monitor perfusion, not pressure alone

MAP is necessary but not sufficient evidence of restored tissue perfusion.

A MAP target of 65 mmHg is a reasonable initial target in septic shock, but hemodynamic stabilization should be judged by end-organ perfusion. Follow urine output, mentation, capillary refill, skin temperature and mottling, lactate, acid-base status, and the trajectory of vasopressor requirement. Failure of these markers to improve should prompt a search for inadequate source control, occult hemorrhage, excessive sedation, myocardial dysfunction, obstruction, or ongoing hypoxemia.ScienceDirectShock (Circulatory) - an overviewPubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

Fluid administration should stop when there is no evidence of benefit or when fluid intolerance emerges. Reassess after each intervention with dynamic testing or stroke-volume response when available, and use lung and cardiac ultrasonography to identify pulmonary congestion or impaired ventricular function. Positive fluid balance and elevated CVP have been associated with worse outcomes in septic shock, but observational associations should not be used as a substitute for individualized assessment.PubMed2023 Update on Sepsis and Septic Shock in Adult Patients

Practical response assessment in distributive shock.ScienceDirectShock (Circulatory) - an overviewPubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedShock - StatPearls - NCBI Bookshelf - NIHPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
DomainWhat to followConcerning finding and next action
PerfusionSerial lactate, capillary refill, skin perfusion, urine output, mentation.ScienceDirectShock (Circulatory) - an overviewPubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024Persistent abnormality: reassess diagnosis, source control, fluid responsiveness, oxygen delivery, and cardiac function.ScienceDirectShock (Circulatory) - an overviewPubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Pressure supportMAP and vasopressor dose.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024MAP below 65 mmHg or rising norepinephrine requirement: add vasopressin when appropriate and evaluate for mixed shock or ongoing volume loss.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Volume statusResponse to fluid bolus, passive leg raise or stroke-volume assessment, echocardiographic preload and congestion findings.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024No response or evidence of congestion: stop routine fluid loading and prioritize vasopressor or cause-specific therapy.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Cardiac functionFocused echocardiography and ECG; consider biomarkers when ischemia is plausible.ScienceDirectShock (Circulatory) - an overviewScienceDirectShock: causes, initial assessment and investigationsPubMedShock - StatPearls - NCBI Bookshelf - NIHNew ventricular dysfunction, pulmonary edema, or arrhythmia: manage mixed cardiogenic physiology and seek specialist support.ScienceDirectShock (Circulatory) - an overviewScienceDirectProtocolised Management of Cardiogenic Shock and Shock Teams: A Narrative Review
RespirationOxygenation, ventilator pressures, lung ultrasound, and hemodynamic effect of positive pressure.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedShock - StatPearls - NCBI Bookshelf - NIHWorsening oxygenation or hypotension after ventilation changes: reassess preload dependence, RV function, and obstructive complications.ScienceDirectShock (Circulatory) - an overviewPubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedShock - StatPearls - NCBI Bookshelf - NIH

Common questions

What distinguishes distributive from hypovolemic shock at the bedside?

Distributive shock is driven by low vascular resistance and may initially have warm skin and preserved or high cardiac output, whereas hypovolemic shock more often has low preload and compensatory vasoconstriction. Overlap is common; use serial perfusion markers, focused ultrasound, and response to a carefully assessed fluid challenge rather than any single sign.ScienceDirectShock (Circulatory) - an overviewScienceDirectShock: causes, initial assessment and investigationsPubMedShock - StatPearls - NCBI Bookshelf - NIH

When should norepinephrine be started in septic shock?

Start norepinephrine when hypotension persists during initial resuscitation or fluid administration alone is unlikely to restore MAP and perfusion. Early vasopressor use may limit fluid overload; use an initial MAP target of 65 mmHg and reassess tissue perfusion continuously.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

When should vasopressin be added to norepinephrine?

Add vasopressin when norepinephrine alone does not achieve the target MAP or when escalating catecholamine exposure is undesirable. It is an adjunct rather than a replacement for norepinephrine in the cited septic-shock guidance.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

Should hydrocortisone be given to every patient with septic shock?

No. Hydrocortisone is reserved for shock that remains dependent on vasopressors despite initial fluids and vasopressor therapy. The cited guidance supports approximately 200 mg/day to facilitate shock recovery; routine use before vasopressor-resistant shock is not supported.PubMed2023 Update on Sepsis and Septic Shock in Adult PatientsPubMedThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

What is the first treatment for anaphylactic shock?

Immediate intramuscular epinephrine is first-line. Position the patient to optimize venous return, administer oxygen and IV fluids for shock, and repeat IM epinephrine after 5 minutes if ABC compromise persists. Antihistamines and corticosteroids must not delay epinephrine.PubMedEmergency treatment of anaphylaxis: concise clinical guidance

References

  1. 3594816 This label may not be the latest approved by FDA ...www.accessdata.fda.gov · www.accessdata.fda.gov
  2. [PDF] 212593Orig1s000 - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  3. Wellbutrin XL - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  4. prescribing information - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  5. 2018 First Generic Drug Approvals | FDAwww.fda.gov · www.fda.gov
  6. 2020 First Generic Drug Approvals | FDAwww.fda.gov · www.fda.gov
  7. 2017 First Generic Drug Approvals | FDAwww.fda.gov · www.fda.gov
  8. 2025 First Generic Drug Approvalswww.fda.gov · www.fda.gov
  9. These highlights do not include all the information needed to use OXYCONTIN<sup>®</sup> safely and effectively. See full prescribing information for OXYCONTIN. <br/> <br/> OXYCONTIN<sup>®</sup> (oxycodone hydrochloride) extended-release tablets, for oral use, CII <br/> Initial U.S. Approval: 1950nctr-crs.fda.gov · nctr-crs.fda.gov
  10. NEJMra1208623_discussion_1www.nejm.org · www.nejm.org
  11. NEJMra1208627_discussion_1www.nejm.org · www.nejm.org
  12. Clinical guideline highlights for the hospitalist: International ...shmpublications.onlinelibrary.wiley.com · shmpublications.onlinelibrary.wiley.com
  13. Evaluation and management of haemorrhagic shock in polytrauma: Clinical practice guidelineswww.sciencedirect.com · www.sciencedirect.com
  14. Shock (Circulatory) - an overviewwww.sciencedirect.com · www.sciencedirect.com
  15. Shock: causes, initial assessment and investigationswww.sciencedirect.com · www.sciencedirect.com
  16. Protocolised Management of Cardiogenic Shock and Shock Teams: A Narrative Reviewwww.sciencedirect.com · www.sciencedirect.com
  17. Book in Review - In Shock by Dr. Rana Awsish | Medical Directors Sectionwww.acep.org · www.acep.org
  18. 2023 Update on Sepsis and Septic Shock in Adult Patientspmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  19. An overview of international cardiogenic shock guidelines ...pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
  20. Shock - StatPearls - NCBI Bookshelf - NIHwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  21. Emergency treatment of anaphylaxis: concise clinical guidancepmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  22. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  23. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐SSCG 2016)pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  24. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine - PubMedpubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov